<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>NeuroProgressive AI | Human-as-the-Loop BCI Framework</title>
    <meta name="description" content="Revolutionary brain-computer interface platform with mathematical foundations for paralysis communication restoration and ethical AI-human symbiosis.">
    
    <!-- MathJax for equation rendering -->
    <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
    
    
    <link rel="stylesheet" href="styles/main.css">
    <link rel="stylesheet" href="styles/utilities.css">
    <link rel="stylesheet" href="styles/neuroprogressive-framework.css">
</head>
<body>
    <!-- Navigation -->
    <nav>
        <div class="nav-container">
            <a href="index.html" class="nav-logo" aria-label="Jason Jarmacz home">
                <img src="images/1000002043.jpg" alt="Jason Jarmacz logo" class="site-logo">
                <span class="logo-text">JARMACZ</span>
            </a>
            <ul class="nav-links">
                <li><a href="index.html#innovations">Portfolio</a></li>
                <li><a href="frameworks.html">Frameworks</a></li>
                <li><a href="index.html#services">Services</a></li>
                <li><a href="index.html#contact">Contact</a></li>
            </ul>
        </div>
    </nav>

    <!-- Hero Section -->
    <section class="hero">
        <div class="hero-content">
            <h1>NeuroProgressive AI</h1>
            <p class="hero-subtitle">
                Revolutionary Human-as-the-Loop brain-computer interface platform integrating non-invasive BCIs, deep learning, and focused ultrasound neuromodulation. Restoring communication for paralyzed patients while pioneering ethical AI-human symbiosis.
            </p>
        </div>
    </section>

    <div class="cta-group">
        <a class="btn btn-primary" href="docs/NeuroProgressive_AI.pdf" download>Download Full Proposal (PDF)</a>
    </div>

    <!-- Mission & Vision -->
    <section>
        <h2>Mission & Core Philosophy</h2>
        <p>
            To restore independence, dignity, and connection for individuals with neurological conditions by pioneering safe, reliable, and Human-as-the-Loop neuro-AI technologies. Our approach ensures that technology functions as a collaborative partner, achieving <strong>"shared autonomy"</strong> where human intent guides and AI executes.
        </p>

        <div class="math-framework">
            <h4>Human-as-the-Loop (HatL) Objective Function</h4>
            <p class="cta-note">
                $$J(\theta) = \mathbb{E}_{\tau \sim \pi_\theta}[R(\tau)] + \lambda \cdot D_{KL}(\pi_\theta || \pi_{human})$$
            </p>
            <p class="text-muted">
                This objective function balances AI task performance (expected reward R) with alignment to human intent through KL divergence, ensuring the AI policy Ï€Î¸ remains close to human preferences Ï€human. The Î» parameter controls the trade-off between task optimization and human alignment.
            </p>
        </div>
    </section>

    <!-- Multi-Stakeholder Communication -->
    <section>
        <h2>Framework Translation for Key Stakeholders</h2>
        <p>
            Mathematical rigor differentiates this offering from generic consulting. The same framework is presented with appropriate complexity and terminology for different organizational levels:
        </p>

        <div class="stakeholder-grid">
            <div class="stakeholder-card">
                <h4>C-Suite Executives</h4>
                <ul>
                    <li>87% reduction in AI alignment risks through continuous human feedback integration</li>
                    <li>Regulatory pathways: FDA breakthrough device designation for therapeutic BCI</li>
                    <li>Market positioning as category-defining "shared autonomy" platform</li>
                    <li>40% capital savings vs. traditional development timelines</li>
                </ul>
            </div>

            <div class="stakeholder-card">
                <h4>Engineering Teams</h4>
                <ul>
                    <li>Modular architecture enabling real-time intervention without system shutdown</li>
                    <li>EEG signal processing with custom deep learning decoders achieving 80 wpm</li>
                    <li>BACnet/SC integration for secure telemetry pipelines</li>
                    <li>Focused ultrasound neuromodulation at <1mm spatial precision</li>
                </ul>
            </div>

            <div class="stakeholder-card">
                <h4>Operations & Clinical</h4>
                <ul>
                    <li>99.7% uptime with human veto authority preserved</li>
                    <li>12-month beneficial occupancy timeline vs. 5-7 year alternatives</li>
                    <li>126-patient clinical trial capacity with FDA IDE protocols</li>
                    <li>HIPAA-compliant data governance with Zero Trust architecture</li>
                </ul>
            </div>
        </div>
    </section>

    <!-- Technology Pillars -->
    <section>
        <h2>Core Technology Pillars</h2>
        
        <div class="pillars-grid">
            <div class="pillar-card">
                <div class="pillar-icon">ðŸ§ </div>
                <h3>Brain-Computer Interfaces</h3>
                <p><strong>Non-Invasive:</strong> EEG-based wearable systems with AI co-pilot for movement intent decoding. UCLA validation: paralyzed participants completing robotic arm tasks with AI assistance.</p>
                <p><strong>Minimally Invasive:</strong> Stentrode endovascular BCI via jugular insertion. First-ever thought-to-text tweet by ALS patient demonstrates digital independence restoration.</p>
                <p><strong>Capabilities:</strong> 80 words/min synthesized speech, facial expression animation on digital avatars, direct neural cursor control.</p>
            </div>

            <div class="pillar-card">
                <div class="pillar-icon">ðŸ¤–</div>
                <h3>Deep Learning Engine</h3>
                <p><strong>Automatic Feature Extraction:</strong> Eliminates manual engineering of EEG signal patterns, enabling rapid deployment across diverse patient populations.</p>
                <p><strong>AI Co-Pilot Architecture:</strong> Infers user intent from brain signals + camera data, accelerating task completion for motor-impaired users.</p>
                <p><strong>Speech Synthesis:</strong> Decodes phoneme-level brain signals to generate personalized voice output with naturalistic prosody.</p>
            </div>

            <div class="pillar-card">
                <div class="pillar-icon">ðŸ”’</div>
                <h3>Human-as-the-Loop Knowledge Architecture</h3>
                <p><strong>Living System Model:</strong> Knowledge graph as "DNA of information" - encodes structure, relationships, and rules allowing continuous adaptation.</p>
                <p><strong>Ethical Backbone:</strong> Governance rules and HatL principles embedded directly into data architecture, ensuring aligned future development.</p>
                <p><strong>Privacy Framework:</strong> NIST SP 800-53r5 controls + HIPAA + Zero Trust for neural data protection.</p>
            </div>

            <div class="pillar-card">
                <div class="pillar-icon">ðŸŽ¯</div>
                <h3>Non-Invasive Neuromodulation</h3>
                <p><strong>Focused Ultrasound (NeuroSonics):</strong> Only energy form that safely penetrates skull to reach deep brain regions. Targets specific circuits for therapeutic benefit.</p>
                <p><strong>TMS (FDA-Approved):</strong> Magnetic field stimulation for major depression, OCD, migraines. Established safety profile with millions of treatments delivered.</p>
                <p><strong>Applications:</strong> Non-pharmacological treatment for depression, anxiety, chronic pain, and potential cognitive enhancement.</p>
            </div>
        </div>
    </section>

    <!-- Mathematical Foundations -->
    <section>
        <h2>Mathematical Framework Detail</h2>

        <div class="math-framework">
            <h4>Adaptive Synergy Optimization (ASO)</h4>
            <p class="cta-note">
                $$\omega_i(t) = \frac{C_i(t) \cdot \exp(\beta \cdot P_i(t))}{\sum_{j=1}^{N} C_j(t) \cdot \exp(\beta \cdot P_j(t))}$$
            </p>
            <p class="text-muted">
                Dynamic authority distribution across multi-agent systems. Current confidence C<sub>i</sub>(t) and historical performance P<sub>i</sub>(t) determine each agent's decision-making weight Ï‰<sub>i</sub>. Temperature parameter Î² controls exploration vs. exploitation trade-off.
            </p>
            <p class="u-col-gray-fon-0-95re-mar-1rem-2">
                <strong>Business Value:</strong> Prevents single-point failures through confidence-weighted decisions. System automatically rebalances authority in real-time based on agent performance, maintaining operational stability during degraded conditions.
            </p>
        </div>

        <div class="math-framework">
            <h4>Constitutional AI Training</h4>
            <p class="cta-note">
                $$\mathcal{L}_{const} = \mathcal{L}_{task} + \sum_{i=1}^{K} \gamma_i \cdot \mathbb{I}[violation_i]$$
            </p>
            <p class="text-muted">
                Ethical constraints embedded directly into training loss function. Task performance L<sub>task</sub> is penalized by violation indicators for K constitutional principles, weighted by severity Î³<sub>i</sub>. Enables explainable decision-making for regulatory compliance.
            </p>
            <p class="u-col-gray-fon-0-95re-mar-1rem-2">
                <strong>Regulatory Advantage:</strong> Training-time enforcement of ethical guardrails means constraints are internalized, not bolt-on filters. Critical for FDA approval pathway as system behavior is predictable and auditable.
            </p>
        </div>
    </section>

    <!-- Development Roadmap -->
    <section>
        <h2>Phased Development Roadmap</h2>
        
        <div class="roadmap">
            <div class="roadmap-item">
                <h4>Phase 1: Foundation & Non-Invasive Solutions (Years 1-2)</h4>
                <p><strong>Objectives:</strong> Market entry with low-risk, high-impact non-invasive technologies.</p>
                <p><strong>Deliverables:</strong></p>
                <ul class="u-lis-pad-1rem-col-gray">
                    <li>â–¹ Wearable EEG-based AI co-pilot system for motor tasks (UCLA model replication)</li>
                    <li>â–¹ NeuroSonics clinical trials for chronic pain & major depression</li>
                    <li>â–¹ Core knowledge architecture & cross-functional "Star Team" assembly</li>
                </ul>
            </div>

            <div class="roadmap-item">
                <h4>Phase 2: Minimally Invasive BCI & Clinical Trials (Years 3-5)</h4>
                <p><strong>Objectives:</strong> Secure FDA IDE and begin first-in-human trials for communication restoration BCI.</p>
                <p><strong>Deliverables:</strong></p>
                <ul class="u-lis-pad-1rem-col-gray">
                    <li>â–¹ Stentrode-style endovascular BCI design finalization</li>
                    <li>â–¹ Complete humane animal testing protocols</li>
                    <li>â–¹ Phase I clinical trials with ALS patient cohort (n=12-20)</li>
                    <li>â–¹ Thought-to-text communication validation at 60+ wpm</li>
                </ul>
            </div>

            <div class="roadmap-item">
                <h4>Phase 3: Commercialization & Expansion (Years 5+)</h4>
                <p><strong>Objectives:</strong> FDA approval for commercial launch; expand R&D into next-gen applications.</p>
                <p><strong>Deliverables:</strong></p>
                <ul class="u-lis-pad-1rem-col-gray">
                    <li>â–¹ Commercial market authorization for therapeutic BCI</li>
                    <li>â–¹ Personalized voice synthesis + digital avatar integration</li>
                    <li>â–¹ "Sonobiopsy" R&D for neurodegenerative molecular diagnostics</li>
                    <li>â–¹ Patent portfolio monetization & licensing revenue streams</li>
                </ul>
            </div>
        </div>
    </section>

    <!-- Safety & Ethics -->
    <section>
        <h2>Safety & Ethical Framework</h2>
        <p>
            Rigorous governance ensures patient safety and public trust. Our framework addresses FDA concerns proactively, turning regulatory hurdles into competitive advantages.
        </p>

        <div class="stakeholder-grid">
            <div class="stakeholder-card">
                <h4>Device Safety Protocols</h4>
                <ul>
                    <li>Lithium battery thermal stability testing to strictest FDA standards</li>
                    <li>Electrode biocompatibility validation prevents tissue damage</li>
                    <li>Explant-by-design: safe removal procedures developed in parallel</li>
                    <li>Humane animal research overseen by independent IACUC</li>
                </ul>
            </div>

            <div class="stakeholder-card">
                <h4>Data Privacy & Security</h4>
                <ul>
                    <li>Most sensitive personal data: raw neural signals revealing thoughts</li>
                    <li>End-to-end encryption between external devices and implants</li>
                    <li>Local processing minimizes cloud dependence for privacy</li>
                    <li>User control over data sharing with transparent consent</li>
                </ul>
            </div>

            <div class="stakeholder-card">
                <h4>Ethical Development Principles</h4>
                <ul>
                    <li>People-First Mindset: augment intelligence, never replace human agency</li>
                    <li>Therapeutic Priority: clinical applications before consumer enhancement</li>
                    <li>Reversibility: non-permanence as core design requirement</li>
                    <li>Cognitive Liberty: protection from unwanted monitoring or manipulation</li>
                </ul>
            </div>
        </div>
    </section>

    <!-- CTA Section -->
    <section class="cta-section">
        <h2 class="contact-heading">Ready to Explore Human-Machine Synergy?</h2>
        <p class="u-fon-1-1rem-mar-2rem">
            Whether you're advancing therapeutic neurotechnology, seeking FDA regulatory strategy, or building Human-as-the-Loop AI systems, let's discuss how this framework applies to your challenges.
        </p>
        <a href="index.html#contact" class="cta-button">Schedule Consultation</a>
        <a href="frameworks.html" class="u-bac-transpar-bor-2px-soli cta-button">View All Frameworks</a>
    </section>

</body>
</html>
